Molecular mechanisms of cholesterol or homocysteine effect in the development of atherosclerosis: Role of vitamin E

BioFactors

Volumn 19, Issue 1-2, 2003, Pages 63-70

  Özer, Nesrin Kartal ^a   Negis, Yesim ^a   Aytan, Nurgul ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Cholesterol; Homocysteine; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; CHOLESTEROL; DNA; HOMOCYSTEINE; HYDROGEN PEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; CELL GROWTH; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DNA SYNTHESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RABBIT; RAT; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0347916886     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520190108     Document Type: Conference Paper

References (44)

1. J.J. Badimon, V. Fuster, J.H. Chesebro and L. Badimon, Coronary atherosclerosis, A multifactorial disesase. Circulation 87 (1993), II-3.
2. R. Ross, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature 362 (1993), 801-809.
3. D. Steinberg, Clinical trials of antioxidants in atherosclerosis: Are we doing the right thing, Lancet 346 (1995), 36-38.
4. E.B. Rimm, M.J. Stampfer, A. Ascherio, E. Giovannucci, G.A. Colditz and W.C. Willett, Vitamin E consumption and the risk of coronary heart disease in men, N. Engl. J. Med. 328 (1993), 1450-1456.
5. M.J. Stampfer, C.H. Hennekens, J.E. Manson, G.A. Colditz, B. Rosner and W.C. Willett, Vitamin E consumption and the risk of coronary disease in women, N. Engl. J. Med. 328 (1993), 1444-1449.
6. K.F. Gey, U.K. Moser, P. Jordan, H.B. Stahelin, M. Eichholzer and E. Ludin, Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C, Am. J. Clin. Nutr. 57 (1993), 787S-797S.
7. M.N. Diaz, B. Frei, J.A. Vita and J.F. Keaney, Antioxidants and atherosclerotic heart disease, N. Engl. J. Med 337 (1997), 408-416.
8. N.G. Stephens, A. Parsons, P.M. Schofield, F. Kelly, K. Cheeseman, M.J. Mitchinson and M.J. Brown, Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet 347 (1996), 781-786.
9. D. Boscoboinik, A. Szewczyk, C. Hensey and A. Azzi, Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C, J. Biol. Chem. 266 (1991), 6188-6194.
10. A. Azzi, D. Boscoboinik, E. Chatelain, N.K. Özer and B. Stäuble, d-alpha-tocopherol control of cell proliferation, Mol. Aspects. Med. 14 (1993), 265-271.
11. D. Boscoboinik, N.K. Özer, U. Moser and A. Azzi, Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit vascular smooth muscle cell proliferation by a nonantioxidant mechanism, Arch. Biochem. Biophys. 318 (1995), 241-246.
12. A. Azzi, D. Boscoboinik, D. Marilley, N.K. Özer, B. Stäuble and A. Tasinato, Vitamin E: A sensor and an information transducer of the cell oxidation state, Am. J. Clin. Nutr. 62 (1995), 1337S-1346S.
13. N.K. Özer, P. Palozza, D. Boscoboinik and A. Azzi, d-alpha-Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells, FEBS Lett. 322 (1993), 307-310.
14. C.J. Boushey, S.A.A. Beresford, G.S. Omenn and A.G. Motulsky, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease, JAMA 274 (1195), 1049-1057.
15. L.M. Taylor, R.D. De Frang, E.J. Harris and J.M. Porter, The association of elevated plasma homocysteine with progression of symptomatic peripheral arteral disease, J. Vasc. Surg 13 (1991), 128-136.
16. O. Nygard, S.E. Vollset and H. Refsum, Total plasma homocysteine and cardiovascular risk profile, J. Am. Med. Assoc. 274 (1995), 1526-1533.
17. M.E. Temple and D.J. Kazierad, Homocysteine as a risk factor for athersclerosis, Cardiology 34 (2000), 57-64.
18. C.D.A. Stehouver, M.P. Weijenberg, M. Van den Berg, C. Jakobs, E.J.M. Feskens and D. Kromhout, Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men-A 10 year follow-up, Arterioscler. Thromb. Vasc. Biol. 18 (1998), 1895-1901.
19. P.M. Ueland, H. Refsum, S.A.A. Beresford and S.E. Vollset, The controversy over homocysteine and cardiovascular risk, Am. J. Clin. Nutr. 72 (2000), 324-332.
20. L.A. Harker, J.M. Harlau and R. Ross, Effect of sulfinpyraizone on homocyst(e)ine-induced endothelial injury and arteriosclerosis in baboons, Circ. Res. 53 (1983), 731-739.
21. D. Matthias, C.H. Becker, R. Riezler and P.H. Kindling, Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine, Atherosclerosis 122 (1996), 201-216.
22. J. Tsai, H. Wang, M.A. Perrella, M. Yoshizumi, N.E.S. Sibinga, L.C. Tan, E. Haber, T.H. Chang, R. Schlegel and M. Lee, Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells, J. Clin. Invest. 97 (1996), 146-153.
23. M.L. Dalton, P.F. Gadson, R.W. Wrenn and T.H. Rosenquist, Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myc in smooth muscle cells, FASEB J. 11 (1997), 703-711.
24. Y. Stein, O. Stein, B. Delplanque, J.D. Fesmire, D.M. Lee and P. Alaupovic, Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels, Atherosclerosis 75 (1989), 145-155.
25. G.A. Ferns, L. Forster, A. Stewart Lee, M. Konneh, J. Nourooz Zadeh and E.E. Anggard, Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit, Proc. Natl. Acad. Sci. USA 89 (1992), 11312-11316.
26. T.M. Bocan, S.B. Mueller, M.J. Mazur, P.D. Uhlendorf, E.Q. Brown and K.A. Kieft, The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation, Atherosclerosis 102 (1993), 9-22.
27. S.V. Mantha, M. Prasad, J. Kalra and K. Prasad, Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits, Atherosclerosis 101 (1993), 135-144.
28. M.K. Konneh, C. Rutherford, S.-R. Li, E.E. Änggrd and G.A.A. Ferns, Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat, Atherosclerosis 113 (1995), 29-39.
29. D.W. Nierenberg and S.L. Nann, A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples, Am. J. Clin. Nutr. 56 (1992), 417-426.
30. O.H. Lowry, N.J. Rosenbrough, A.L. Farr and R.J. Randall, Protein measurements with the Folin reagent, J. Biol. Chem. 193 (1951), 265-271.
31. S.L. Godfried, G.F. Combs, Jr., J.M. Saroka and L.A. Dillingham, Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E, Br. J. Nutr. 61 (1989), 607-617.
32. R.B. Wilson, C.C. Middleton and G.Y. Sun, Vitamin E antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits, J. Nutr. 108 (1978), 1858-1867.
33. J. Bitman, J. Weyant, D.L. Wood and T.R. Wrenn, Vitamin E, cholesterol, and lipids during atherogenesis in rabbits, Lipids 11 (1976), 449-461.
34. I. Bjorkhem, A. Henriksson Freyschuss, O. Breuer, U. Diczfalusy, L. Berglund and P. Henriksson, The antioxidant butylated hydroxytoluene protects against atherosclerosis, Arterioscler. Thromb. 11 (1991), 15-22.
35. D.W. Morel, M. De la Llera-Moya and K.E. Friday, Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis, J. Nutr. 124 (1994), 123-2130.
36. Ö. Sirikci, N.K. Özer and A. Azzi, Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells, Atherosclerosis 126 (1996), 253-263.
37. H. Esterbauer, G. Waeg, H. Puhl, M. Dieber Rotheneder and F. Tatzber, Inhibition of LDL oxidation by antioxidants, EXS. 62 (1992), 145-157.
38. J. Neuzil, C. Weber and A. Kontush, The role of vitamin E in atherogenesis: linking the chemical biological and clinical aspects of the disease, Atherosclerosis 157 (2001), 257-283.
39. N.K. Özer, D. Boscoboinik and A. Azzi, New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis, Biochem. Mol. Biol. Int. 35 (1995), 117-124.
40. D. Boscoboinik, A. Szewczyk and A. Azzi, Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity, Arch. Biochem. Biophys. 286 (1991), 264-269.
41. G. Starkebaum and J.M. Harlan, Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocyst(e)ine, J. Clin. Invest. 77 (1986), 1370-1376.
42. 2 for platelet-derived growth factor signal transduction, Science 270 (1995), 296-299.
43. J. Tsai, M.A. Perrella, M. Yoshizumi, C. Hsieh, E. Haber, R. Schlegel and M. Lee, Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis, Proc. Natl. Acad. Sci. USA 91 (1994), 6369-6373.
44. J.C. Brown, T.H. Rosenquist and D.T. Monaghan, ERK2 Activation by homocysteine in vascular smooth muscle cells, Biochem. Biophys. Res. Commun. 251 (1998), 669-676.